The University of Chicago Header Logo

Connection

Tao Xie to Parkinson Disease

Back to Details
This is a "connection" page, showing publications Tao Xie has written about Parkinson Disease.
Tao Xie
Connection Strength
5.764
Parkinson Disease
  1. Comment on: "A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease". Mov Disord. 2024 Apr; 39(4):760-761.
    View in: PubMed
    Score: 0.820
  2. Disparities in diagnosis, treatment and survival between Black and White Parkinson patients. Parkinsonism Relat Disord. 2021 06; 87:7-12.
    View in: PubMed
    Score: 0.668
  3. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. J Neurol Neurosurg Psychiatry. 2018 09; 89(9):989-994.
    View in: PubMed
    Score: 0.542
  4. Comments on the recent viewpoint article on low-frequency deep brain stimulation for Parkinson's disease. Mov Disord. 2017 01; 32(1):176.
    View in: PubMed
    Score: 0.491
  5. Author Response. Neurology. 2015 Aug 11; 85(6):557.
    View in: PubMed
    Score: 0.450
  6. Respiratory dyskinesia in a patient with Parkinson disease successfully treated with STN DBS. Neurology. 2015 Aug 04; 85(5):479-80.
    View in: PubMed
    Score: 0.447
  7. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015 Jan 27; 84(4):415-20.
    View in: PubMed
    Score: 0.431
  8. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology. 2012 Oct 16; 79(16):1744; author reply 1744.
    View in: PubMed
    Score: 0.370
  9. Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2012 Oct; 83(10):1015-7.
    View in: PubMed
    Score: 0.362
  10. Using global team science to identify genetic parkinson's disease worldwide. Ann Neurol. 2019 08; 86(2):153-157.
    View in: PubMed
    Score: 0.295
  11. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism. Hum Brain Mapp. 2019 12 01; 40(17):5094-5107.
    View in: PubMed
    Score: 0.149
  12. Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism Relat Disord. 2019 08; 65:178-183.
    View in: PubMed
    Score: 0.147
  13. Catechol-O-methyltransferase inhibitors in Parkinson's disease. Lancet. 1998 Jun 27; 351(9120):1966.
    View in: PubMed
    Score: 0.137
  14. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Mov Disord. 2018 02; 33(2):282-288.
    View in: PubMed
    Score: 0.132
  15. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Mov Disord. 1997 May; 12(3):426-7.
    View in: PubMed
    Score: 0.127
  16. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Mov Disord. 2016 06; 31(6):924-32.
    View in: PubMed
    Score: 0.118
  17. Further studies in xenobiotic metabolism and Parkinson's disease. Adv Neurol. 2001; 86:105-13.
    View in: PubMed
    Score: 0.041
  18. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. Lancet Digit Health. 2019 09; 1(5):e222-e231.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.